Multiverse News

BrainProbers, a start-up company focused on biomedical implant products, has been given approval by the Food and Drug Administration to begin human trials to test their new brain implant, called Wetware Ads. Unlike other implants available in the market today, Wetware Ads will directly place advertising impressions into a user's brain. Competing brain implant companies have focused on human augmentation and interfacing with software to improve human capabilities or to help disabled people. BrainProbers, supported by investments from major advertising companies and Big Tech, are taking the technology in a different direction. With the initial release of the technology, the implants will directly insert fully immersive and targeted advertising impressions into the brain. The next planned release will add the ability to measure the effectiveness of the advertisements through the user's thoughts and actions. The user's cogitations and beliefs will be collected by the implant and shared with the advertisers to tune their advertising campaigns, develop more effectual advertising content, and measure the overall value of their advertising investments. BrainProbers Wetware Ads will be provided free to users, including the implantation and all follow-on medical services, except the removal of the implant at service termination. The Wetware Ads Terms of Service have raised alarms with the Electronic Freedom Foundation, which highlighted language that shows BrainProbers and its advertisers will record and own all of the user's thoughts in perpetuity. The USDA is investigating the company for its treatment of animals during testing, where more than 3,000 animals were killed in the research and testing of the implants. The CEO, under pressure from advertisers and investors, indicated in an interview that the company will kill an additional 3,000 animals in the next six months to get the implants into humans faster.